THEODORE MATEJKA: Open Payments
NPI 1396742490 · DAYTONA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,604 in 50 payments from 17 companies in 2025. Trend: 2023 $2,551 · 2024 $3,298 · 2025 $2,604
Food & beverage: $2,597Education: $7
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 7 | $396 |
| Vanda Pharmaceuticals Inc. | 8 | $335 |
| Alexion Pharmaceuticals, Inc. | 2 | $267 |
| Gilead Sciences, Inc. | 2 | $259 |
| Otsuka America Pharmaceutical, Inc. | 5 | $202 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $151 |
| Edwards Lifesciences Corporation | 1 | $139 |
| Teva Pharmaceuticals USA, Inc. | 3 | $136 |
| Apellis Pharmaceuticals, Inc. | 1 | $120 |
| SANOFI-AVENTIS U.S. LLC | 1 | $101 |
Products named: INGREZZA, FANAPT, STRENSIQ, CAPLYTA, SAPIEN 3 Ultra RESILIA, AUSTEDO XR, Livdelzi, Epclusa.
Industry payments across FL — which companies pay providers there.
